Publication | Open Access
Sulindac (K-80003) with nab-paclitaxel and gemcitabine overcomes drug-resistant pancreatic cancer
22
Citations
40
References
2024
Year
Pancreatic CancerMedicinePharmacologyPharmacotherapyAnti-cancer AgentCancer TreatmentOncologyRadiation OncologyCancer ResearchDrug Discovery
| Year | Citations | |
|---|---|---|
Page 1
Page 1